NeuroVive and CRO Selcia will develop drugs targeting mitochondrial physiology and pathophysiology

NeuroVive Pharmaceutical AB

Sweden / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Selcia Ltd.

U.K. / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced